RxDoctor Payments Data
★ My doctorsLook up a doctor →

James del Rosso

MOHS-Micrographic Surgery · Las Vegas, NVNPI 1083636369

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $2,549,447 of the $3,612,246 with a category attached, or 70.6%. It is spread thinly across 43 manufacturers, the largest accounting for just 11.3%.

$3,612,246in general payments, 2019–2025

Across 2,581 payments — averaging $1399.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$409K
  • Sanofi$406K
  • Regeneron Healthcare Solutions, Inc.$343K
  • Arcutis Biotherapeutics, Inc.$302K
  • Galderma Laboratories, L.p.$265K
  • UCB, Inc.$241K
  • plus $1.6M from 37 others
$1,785,700in research payments, 2019–2025

Across 410 payments — averaging $4355.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Incyte Corporation$537K
  • Bausch Health US, LLC$218K
  • Eli Lilly$203K
  • Amgen$145K
  • Aclaris Therapeutics, Inc.$128K
  • E.r. Squibb & Sons, L.L.C.$127K
  • plus $429K from 12 others

What the payments were for

  • Consulting fees$713,62720%
  • Speaking & faculty fees$2,549,44771%
  • Travel & lodging$247,1357%
  • Food & beverage$53,9311%
  • Education$48,1071%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sun Pharmaceutical Industries Inc.195$408,929
Sanofi186$405,631
Regeneron Healthcare Solutions, Inc.221$342,982
Arcutis Biotherapeutics, Inc.288$301,889
Galderma Laboratories, L.p.178$265,310
UCB, Inc.216$240,619
LEO Pharma Inc.143$223,129
E.r. Squibb & Sons, L.L.C.225$192,822
Lilly USA, LLC131$168,643
Incyte Corporation120$146,108
Almirall LLC98$144,822
Pfizer63$132,696
Amgen95$97,885
Ortho Dermatologics, A Division Of Bausch Health US, LLC61$92,672
Dermavant Sciences, Inc.71$87,503
AbbVie64$65,634
EPI Health, LLC42$48,499
VYNE Pharmaceuticals Inc.30$47,054
Dermira, Inc.20$37,047
Mayne Pharma Commercial LLC13$26,348
Encore Dermatology Inc.2$20,021
Organon10$17,373
Aclaris Therapeutics, Inc.12$14,477
Bristol Myers Squibb24$9,578
LNHC, Inc5$9,329
Galderma International SAS2$8,900
Stemline Therapeutics Inc.9$8,702
Journey Medical Corporation8$7,363
Biofrontera Inc.5$7,168
Verrica Pharmaceuticals Inc.8$6,972
Eli Lilly5$5,219
Promius Pharma LLC1$4,000
Mindera Corp1$3,500
Galderma Research & Development, LLC1$3,200
LEO Pharma AS1$2,820
Janssen Scientific Affairs, LLC3$2,724
Boehringer Ingelheim1$2,100
Sanofi Pasteur Inc.1$1,624
Sanofi-aventis U.S. LLC8$332
Regeneron5$256
Johnson & Johnson(2 entities)5$164
Blueprint Medicines Corporation2$116
Novartis2$85

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few mohs-micrographic surgery providers in Nevadato place this figure against a meaningful peer group, so we don't.

Other mohs-micrographic surgery in Las Vegas

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →